At a glance
ClinicalIndex Comparison RecordN/ACompleted· 125 enrolled
Drug / intervention
misoprostol +1 moredrug
Likely dose
misoprostol 400mcgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cervical Preparation Before Same-day Second Trimester Abortion With Buccal Misoprostol Versus Dilapan-S: A Randomized Placebo Controlled Trial
In Brief
A clinical study evaluating misoprostol and Dilapan-S, vitamin B-12 for Cervical Ripening. Completed, enrolled 125 participants across 1 site.
Detailed Summary
The purpose of this study is to compare the dilatory effect of 400 mcg of buccally administered misoprostol to one Dilapan-S rod placed 3-4 hours before abortion by dilation and evacuation in women who are 12 weeks 0 days to 15 weeks 0 days gestation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCervical Ripening
CountriesUnited States
CollaboratorsSociety of Family Planning
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2009
First PostedFeb 2009
Primary CompletionDec 2011
TodayJul 2026
First PostedFeb 4, 2009
Enrollment StartJan 1, 2009
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 17.4 years ago
Interventions
misoprostoldrug
400mcg misoprostol, buccal administration, 1 time dosing 3-4 hours before abortion by D\&E
Dilapan-S, vitamin B-12device
One Dilapan-S rod placed in the cervix 3-4 hours before abortion by D\&E. Control: 1000mcg vitamin B-12, buccal administration 3-4 hours before abortion by D\&E